World Journal of Surgery

, Volume 34, Issue 6, pp 1380–1385 | Cite as

Laparoscopic Resection is Inappropriate in Patients with Known or Suspected Adrenocortical Carcinoma

  • B. S. MillerEmail author
  • J. B. Ammori
  • P. G. Gauger
  • J. T. Broome
  • G. D. Hammer
  • G. M. Doherty



Complete surgical resection is the mainstay of treatment for patients with adrenocortical cancer (ACC). Use of laparoscopy has been questioned in patients with ACC. This study compares the outcomes of patients undergoing laparoscopic versus open resection (OR) for ACC.


A retrospective review (2003–2008) of patients with ACC was performed. Data were collected for demographics, operative and pathologic data, adjuvant therapy, and outcome. Chi-square analysis was performed.


Eighty-eight patients (66% women; median age, 47 (range, 18–81) years) were identified. Seventeen patients underwent laparoscopic adrenalectomy (LA). Median tumor size of those who underwent LA was 7.0 (range, 4–14) cm versus 12.3 (range, 5–27) cm for OR. Recurrent disease in the laparoscopic group occurred in 63% versus 65% in the open group. Mean time to first recurrence for those who underwent LA was 9.6 months (±14) versus 19.2 months (±37.5) in the open group (p < 0.005). Fifty percent of patients who underwent LA had positive margins or notation of intraoperative tumor spill versus 18% of those who underwent OR (p = 0.01). Local recurrence occurred in 25% of the laparoscopic group versus 20% in the open group (p = 0.23). Mean follow-up was 36.5 months (±43.6).


ACC continues to be a deadly disease, and little to no progress has been made from a treatment standpoint in the past 20 years. Careful and complete surgical resection is of the utmost importance. Although feasible in many cases and tempting, laparoscopic resection should not be attempted in patients with tumors suspicious for or known to be adrenocortical carcinoma.


Local Recurrence Laparoscopic Group Laparoscopic Resection Laparoscopic Adrenalectomy Open Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bilimoria KY, Shen WT, Elaraj D et al (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113(11):3130–3136CrossRefPubMedGoogle Scholar
  2. 2.
    National Cancer Institute Cancer Center Programs.
  3. 3.
    National Institutes of Health (2002) Management of the clinically inapparent adrenal mass (incidentaloma). State-of-the-science conference statement. http://consensus.nih.gove/2002/2002AdrenalIncidentalomasos021html.htm. Accessed 4-6 Feb 2002
  4. 4.
    Gagner M, Lacroix A, Bolte E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma [letter]. N Engl J Med 327:1033PubMedCrossRefGoogle Scholar
  5. 5.
    Gagner M, Lacroix A, Prinz RA et al (1993) Early experience with laparoscopic approach for adrenalectomy. Surgery 114:1120–1125PubMedGoogle Scholar
  6. 6.
    Gonzalez RJ, Shapiro S, Sarlis N et al (2005) Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery 138:1078–1086CrossRefPubMedGoogle Scholar
  7. 7.
    Zafar SS, Abaza R (2008) Robot-assisted laparoscopic adrenalectomy for adrenocortical carcinoma: initial report and review of the literature. J Endourol 22(5):985–989CrossRefPubMedGoogle Scholar
  8. 8.
    Cobb WS, Kercher KW, Sing RF et al (2005) Laparoscopic adrenalectomy for malignancy. Am J Surg 189:405–411CrossRefPubMedGoogle Scholar
  9. 9.
    Kendrick ML, Lloyd R, Erickson L et al (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136:543–549CrossRefPubMedGoogle Scholar
  10. 10.
    Vassiolopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma: clinical outcome at the end of the 20th century. Cancer 92(5):1113–1121CrossRefGoogle Scholar
  11. 11.
    Saunders BD, Wainess RM, Dimick JB et al (2004) Trends in utilization of adrenalectomy in the United States: have indications changed? World J Surg 28:1169–1175CrossRefPubMedGoogle Scholar
  12. 12.
    Eto M, Hamaguchi M, Harano M et al (2008) Laparoscopic adrenalectomy for malignant tumors. Intl J Urol 15:295–298CrossRefGoogle Scholar
  13. 13.
    Ramacciato G, Mercantini P, La Torre M et al (2008) Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc 22:516–521CrossRefPubMedGoogle Scholar
  14. 14.
    Porpiglia F, Fiori C, Tarabuzzi R et al (2004) Is laparoscopic adrenalectomy feasible for adrenocortical carcinoma or metastasis? BJU Int 94:1026–1029CrossRefPubMedGoogle Scholar
  15. 15.
    Henry JF, Sebag F, Iacobone M et al (2002) Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 26:1043–1047CrossRefPubMedGoogle Scholar
  16. 16.
    Soon PSH, Yeh MW, Delbridge LW et al (2008) Laparoscopic surgery is safe for large adrenal lesions. EJSO 34:67–70PubMedGoogle Scholar
  17. 17.
    Corcione F, Miranda L, Marzano E et al (2005) Laparoscopic adrenalectomy for malignant neoplasm. Our experience in 15 cases. Surg Endosc 19:841–844CrossRefPubMedGoogle Scholar
  18. 18.
    Kirshtein B, Yelle JD, Moloo H et al (2008) Laparoscopic adrenalectomy for adrenal malignancy: a preliminary report comparing the short-term outcomes with open adrenalectomy. J Laparoendosc Adv Surg Tech 18(1):42–46CrossRefGoogle Scholar
  19. 19.
    Dackiw APB, Lee JE, Gagel RF et al (2001) Adrenal cortical carcinoma. World J Surg 25:914–926CrossRefPubMedGoogle Scholar
  20. 20.
    Guerrieri M, Campagnacci R, De Sanctis A et al (2008) The learning curve in laparoscopic adrenalectomy. J Endocrinol Invest 31:531–536PubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • B. S. Miller
    • 1
    Email author
  • J. B. Ammori
    • 1
  • P. G. Gauger
    • 1
  • J. T. Broome
    • 3
  • G. D. Hammer
    • 2
  • G. M. Doherty
    • 1
  1. 1.Division of Endocrine SurgeryUniversity of MichiganAnn ArborUSA
  2. 2.Division of Metabolism, Endocrinology, and DiabetesUniversity of MichiganAnn ArborUSA
  3. 3.Division of Surgical Oncology and Endocrine SurgeryVanderbilt UniversityNashvilleUSA

Personalised recommendations